Nima Rezaei

InstitutionTehran University of Medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 124 Covid-19 publications, with a maximum of 28 publications in January 2021
    All Publications
    Bar chart showing 600 publications over 20 distinct years, with a maximum of 64 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The role of type I interferon in the treatment of COVID-19. J Med Virol. 2022 01; 94(1):63-81. PMID: 34468995.
      Citations: 2     Fields:    Translation:Humans
    2. Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2022 01; 94(1):54-62. PMID: 34427929.
      Citations: 3     Fields:    Translation:Humans
    3. Tantuoyir MM, Rezaei N. Serological tests for COVID-19: Potential opportunities. Cell Biol Int. 2021 11; 45(11):2199-2200. PMID: 34374484.
      Citations:    Fields:    Translation:Humans
    4. Sazgarnejad S, Yazdanpanah N, Rezaei N. Anti-inflammatory effects of GLP-1 in patients with COVID-19. Expert Rev Anti Infect Ther. 2021 Aug 12; 1-9. PMID: 34348067.
      Citations: 1     Fields:    
    5. Nowroozi A, Rezaei N. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant of concern breakthrough infections: Are vaccines failing us? Infect Control Hosp Epidemiol. 2021 Aug 06; 1-2. PMID: 34353385.
      Citations: 1     Fields:    
    6. Redwan EM, Alghamdi MF, El-Aziz TMA, Adadi P, Aljabali AAA, Attrish D, Azad GK, Baetas-da-Cruz W, Barh D, Bazan NG, Brufsky AM, Chauhan G, Hassan SKS, Kandimalla R, Lal A, Lundstrom K, Mishra YK, Choudhury PP, Palù G, Panda PK, Pizzol D, Rezaei N, Serrano-Aroca Á, Sherchan SP, Seyran M, Takayama K, Tambuwala MM, Uhal BD, Uversky VN. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19. Autoimmun Rev. 2021 10; 20(10):102909. PMID: 34274539.
      Citations: 1     Fields:    Translation:Humans
    7. Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, Sherchan SP, Azad GK, Rezaei N, Serrano-Aroca Á, Bazan NG, Hassan SS, Panda PK, Pal Choudhury P, Pizzol D, Kandimalla R, Baetas-da-Cruz W, Mishra YK, Palu G, Brufsky AM, Tambuwala MM, Uversky VN. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Biomolecules. 2021 07 13; 11(7). PMID: 34356644.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    8. Saleki K, Yaribash S, Banazadeh M, Hajihosseinlou E, Gouravani M, Saghazadeh A, Rezaei N. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies. Eur J Pharmacol. 2021 Sep 05; 906:174248. PMID: 34126092.
      Citations: 1     Fields:    Translation:Humans
    9. Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci. 2022 01 27; 33(1):79-92. PMID: 34087964.
      Citations:    Fields:    Translation:Humans
    10. Keshavarz P, Yazdanpanah F, Azhdari S, Kavandi H, Nikeghbal P, Bazyar A, Rafiee F, Nejati SF, Sadabad FE, Rezaei N. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome. J Med Virol. 2021 Sep; 93(9):5458-5473. PMID: 33969513.
      Citations:    Fields:    Translation:Humans
    11. Farmani AR, Mahdavinezhad F, Moslemi R, Mehrabi Z, Noori A, Kouhestani M, Noroozi Z, Ai J, Rezaei N. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol. 2021 Jun; 43(3):259-264. PMID: 34018464.
      Citations: 4     Fields:    Translation:HumansCells
    12. Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic. Acta Biomed. 2021 05 12; 92(2):e2021102. PMID: 33988147.
      Citations:    Fields:    Translation:HumansPHPublic Health
    13. Citations:    
    14. Noori M, Nejadghaderi SA, Rezaei N. "Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants. Infect Control Hosp Epidemiol. 2021 May 03; 1-2. PMID: 33938416.
      Citations: 4     Fields:    
    15. Sargazi S, Sheervalilou R, Rokni M, Shirvaliloo M, Shahraki O, Rezaei N. The role of autophagy in controlling SARS-CoV-2 infection: An overview on virophagy-mediated molecular drug targets. Cell Biol Int. 2021 Aug; 45(8):1599-1612. PMID: 33818861.
      Citations: 3     Fields:    Translation:Humans
    16. Hassan SS, Attrish D, Ghosh S, Choudhury PP, Uversky VN, Aljabali AAA, Lundstrom K, Uhal BD, Rezaei N, Seyran M, Pizzol D, Adadi P, Soares A, Abd El-Aziz TM, Kandimalla R, Tambuwala MM, Azad GK, Sherchan SP, Baetas-da-Cruz W, Lal A, Palù G, Takayama K, Serrano-Aroca Á, Barh D, Brufsky AM. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2. Int J Biol Macromol. 2021 Jun 30; 181:801-809. PMID: 33862077.
      Citations: 7     Fields:    Translation:Humans
    17. Pourriyahi H, Saghazadeh A, Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. J Neuroimmunol. 2021 07 15; 356:577578. PMID: 33933818.
      Citations:    Fields:    Translation:HumansPHPublic Health
    18. Citations: 12     Fields:    Translation:Humans
    19. Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet. 2021 07; 304(1):5-38. PMID: 33797605.
      Citations: 5     Fields:    Translation:Humans
    20. Mohammadi T, Nasab MG, Mohebalizadeh M, Kheirandish A, Saghazadeh A, Rezaei N. Dynamic Antibody Response: a Biomarker for COVID-19. Clin Lab. 2021 Apr 01; 67(4). PMID: 33865266.
      Citations:    Fields:    Translation:Humans
    21. Ahmadi M, Pashangzadeh S, Mousavi P, Saffarzadeh N, Amin Habibi M, Hajiesmaeili F, Rezaei N. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol. 2021 Jun; 95:107568. PMID: 33765612.
      Citations: 1     Fields:    Translation:HumansCells
    22. Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol. 2021 11; 31(6):e2234. PMID: 33724604.
      Citations: 1     Fields:    Translation:HumansCells
    23. Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol. 2021 Mar 16; 21(1):116. PMID: 33726699.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    24. Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Mater. 2021; 4(1):293-312. PMID: 33718777.
      Citations: 2     
    25. Seyran M, Hassan SS, Uversky VN, Pal Choudhury P, Uhal BD, Lundstrom K, Attrish D, Rezaei N, Aljabali AAA, Ghosh S, Pizzol D, Adadi P, El-Aziz TMA, Kandimalla R, Tambuwala MM, Lal A, Azad GK, Sherchan SP, Baetas-da-Cruz W, Palù G, Brufsky AM. Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks. Biomolecules. 2021 03 09; 11(3). PMID: 33803118.
      Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    26. Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? Int J Health Serv. 2022 01; 52(1):9-22. PMID: 33686893.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    27. Kafieh R, Arian R, Saeedizadeh N, Amini Z, Serej ND, Minaee S, Yadav SK, Vaezi A, Rezaei N, Haghjooy Javanmard S. COVID-19 in Iran: Forecasting Pandemic Using Deep Learning. Comput Math Methods Med. 2021; 2021:6927985. PMID: 33680071.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    28. Pezeshki PS, Rezaei N. Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opin Biol Ther. 2021 09; 21(9):1173-1179. PMID: 33543652.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    29. Khanmohammadi S, Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19. J Med Virol. 2021 May; 93(5):2735-2739. PMID: 33506952.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    30. Zarandi PK, Zinatizadeh MR, Zinatizadeh M, Yousefi MH, Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. Biomed Pharmacother. 2021 May; 137:111352. PMID: 33550050.
      Citations: 4     Fields:    Translation:Humans
    31. Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises. Stem Cell Rev Rep. 2021 02; 17(1):163-175. PMID: 32564256.
      Citations: 14     Fields:    Translation:HumansCells
    32. Razavi A, Hamblin MR, Rezaei N. COVID-19 in patients with cancer: Risks and precautions. Am J Emerg Med. 2021 10; 48:357-360. PMID: 33546958.
      Citations: 2     Fields:    Translation:HumansCells
    33. Jabalameli N, Rajabi F, Firooz A, Rezaei N. The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases. Immunol Invest. 2021 Jan 26; 1-8. PMID: 33494631.
      Citations: 3     Fields:    
    34. Peymani P, Dehesh T, Aligolighasemabadi F, Sadeghdoust M, Kotfis K, Ahmadi M, Mehrbod P, Iranpour P, Dastghaib S, Nasimian A, Ravandi A, Kidane B, Ahmed N, Sharma P, Shojaei S, Bagheri Lankarani K, Madej A, Rezaei N, Madrakian T, Los MJ, Labouta HI, Mokarram P, Ghavami S. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun. 2021; 6(1):3. PMID: 33521322.
      Citations: 13     
    35. Tantuoyir MM, Rezaei N. Serological tests for COVID-19: Potential opportunities. Cell Biol Int. 2021 Apr; 45(4):740-748. PMID: 33289157.
      Citations: 2     Fields:    Translation:Humans
    36. Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep. 2021 Mar; 9(3):1279-1282. PMID: 33768826.
      Citations: 3     
    37. Salehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis. J Affect Disord. 2021 03 01; 282:527-538. PMID: 33433382.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    38. Gholami B, Gholami S, Loghman AH, Khodaei B, Seyedpour S, Seyedpour N, Saghazadeh A, Rezaei N. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease. Adv Exp Med Biol. 2021; 1318:369-402. PMID: 33973190.
      Citations:    Fields:    Translation:HumansPHPublic Health
    39. Moallemian Isfahani M, Emam-Djomeh Z, Rao IM, Rezaei N. Nutrition and Immunity in COVID-19. Adv Exp Med Biol. 2021; 1318:485-497. PMID: 33973196.
      Citations:    Fields:    Translation:HumansPHPublic Health
    40. Moossavi S, Fehr K, Maleki H, Seyedpour S, Keshavarz-Fathi M, Tabasi F, Heravi M, Sharifian R, Shafiei G, Badihian N, Kelishadi R, Nematollahi S, Almasi M, Popescu S, Keshavarz-Fathi M, Rezaei N. Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions. Adv Exp Med Biol. 2021; 1318:575-604. PMID: 33973200.
      Citations:    Fields:    Translation:Humans
    41. Mojtabavi H, Javidi N, Naviaux AF, Janne P, Gourdin M, Mohammadpour M, Saghazadeh A, Rezaei N. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the COVID-19 Pandemic. Adv Exp Med Biol. 2021; 1318:687-703. PMID: 33973206.
      Citations:    Fields:    Translation:HumansPHPublic Health
    42. Kolahchi Z, De Domenico M, Uddin LQ, Cauda V, Grossmann I, Lacasa L, Grancini G, Mahmoudi M, Rezaei N. COVID-19 and Its Global Economic Impact. Adv Exp Med Biol. 2021; 1318:825-837. PMID: 33973214.
      Citations:    Fields:    Translation:HumansPHPublic Health
    43. Mohamed K, Makuku R, Rodríguez-Román E, Hejleh APA, Joya M, Ivanovska M, Makka SA, Islam MS, Radwan N, Faten AB, Xiao C, Marquez L, Rezaei N. A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader. Adv Exp Med Biol. 2021; 1318:891-910. PMID: 33973218.
      Citations:    Fields:    Translation:HumansPHPublic Health
    44. Momtazmanesh S, Samieefar N, Uddin LQ, Ulrichs T, Kelishadi R, Roudenok V, Karakoc-Aydiner E, Salunke DB, Nouwen JL, Becerra JCA, Vieira DN, Goudouris E, Jamee M, Khafaie MA, Shamsizadeh M, Golabchi MR, Samimiat A, Doostkamel D, Afshar A, Tabari MAK, Lotfi M, Boroujeni RY, Rambod N, Stashchak A, Volokha A, Pavalkis D, Pereira A, Latiff AHA, Baylarov R, Amirheidari B, Ch MH, Condino-Neto A, Rezaei N. Socialization During the COVID-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing. Adv Exp Med Biol. 2021; 1318:911-921. PMID: 33973219.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    45. Citations: 1     Fields:    Translation:HumansPHPublic Health
    46. Rezaei N, Vahed A, Ziaei H, Bashari N, Afkham SA, Bahrami F, Bakhshi S, Ghanadan A, Ghanadan A, Hosseini N, Kafi P, Khalilianfard R, Mohammed K, Sargoli S, Tavasoli K, Zare M, Saghazadeh A. Health and Art (HEART): Integrating Science and Art to Fight COVID-19. Adv Exp Med Biol. 2021; 1318:937-964. PMID: 33973221.
      Citations:    Fields:    Translation:HumansPHPublic Health
    47. Ahanchian H, Moazzen N, Saeidinia A, Joghatayi SH, Khoshkhui M, Aelami MH, Haghi NSM, Rezaei N. Death Due to COVID-19 in an Infant with Combined Immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2021; 21(9):1649-1652. PMID: 33087035.
      Citations: 5     Fields:    Translation:Humans
    48. Torabi-Rahvar M, Rezaei N. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm. Curr Pharm Des. 2021; 27(13):1549-1552. PMID: 33238863.
      Citations: 3     Fields:    Translation:Humans
    49. Rezaei N, Ashkevarian S, Fathi MK, Hanaei S, Kolahchi Z, Ladi Seyedian SS, Rayzan E, Sarzaeim M, Vahed A, Mohamed K, Momtazmanesh S, Moradian N, Pirkoohi ZR, Sameeifar N, Yousefpour M, Sargoli S, Adiban S, Vahed A, Yazdanpanah N, Ziaei H, Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. Adv Exp Med Biol. 2021; 1318:1-22. PMID: 33973169.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    50. Hanaei S, Mohebi F, Moradi-Lakeh M, Jabbari P, Mehta SK, Kryvenko LS, Luongo L, Dupré L, Rezaei N. The Epidemiologic Aspects of COVID-19 Outbreak: Spreading Beyond Expectations. Adv Exp Med Biol. 2021; 1318:61-79. PMID: 33973172.
      Citations:    Fields:    Translation:HumansPHPublic Health
    51. Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol. 2021; 1318:91-107. PMID: 33973174.
      Citations: 1     Fields:    Translation:Humans
    52. Saghazadeh A, Rezaei N. How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment. Adv Exp Med Biol. 2021; 1318:119-147. PMID: 33973176.
      Citations:    Fields:    Translation:HumansCells
    53. Akbarpour M, Sharifi L, Safdarian AR, Farhangnia P, Borjkhani M, Rezaei N. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV. Adv Exp Med Biol. 2021; 1318:149-167. PMID: 33973177.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    54. Eskian M, Rezaei N. Clinical Manifestations of COVID-19. Adv Exp Med Biol. 2021; 1318:179-196. PMID: 33973179.
      Citations:    Fields:    Translation:HumansPHPublic Health
    55. Mirbeyk M, Saghazadeh A, Rezaei N. Geriatrics and COVID-19. Adv Exp Med Biol. 2021; 1318:209-222. PMID: 33973181.
      Citations:    Fields:    Translation:Humans
    56. Quinaglia T, Shabani M, Rezaei N. COVID-19 in Patients with Hypertension. Adv Exp Med Biol. 2021; 1318:243-261. PMID: 33973183.
      Citations:    Fields:    Translation:Humans
    57. Fotouhi M, Samami E, Mohseni S, Nasrollahizadeh A, Haddadi M, Mirbeyk M, Saghazadeh A, Rezaei N. How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes? Adv Exp Med Biol. 2021; 1318:293-313. PMID: 33973185.
      Citations:    Fields:    Translation:HumansCells
    58. Nowroozi A, Razi S, Sahu KK, Grizzi F, Arends J, Keshavarz-Fathi M, Rezaei N. COVID-19 in Patients with Cancer. Adv Exp Med Biol. 2021; 1318:315-331. PMID: 33973186.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    59. Delavari F, Varzaneh FN, Rezaei N. Neurologic Manifestations of COVID-19. Adv Exp Med Biol. 2021; 1318:343-353. PMID: 33973188.
      Citations: 1     Fields:    Translation:Humans
    60. Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M, Aljabali AAA, Lal A, Azad GK, Azad GK, Choudhury PP, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Questions concerning the proximal origin of SARS-CoV-2. J Med Virol. 2021 03; 93(3):1204-1206. PMID: 32880995.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    61. Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk. Rev Neurosci. 2021 04 27; 32(3):341-349. PMID: 33580645.
      Citations: 1     Fields:    Translation:Humans
    62. Seyran M, Takayama K, Uversky VN, Lundstrom K, Palù G, Sherchan SP, Attrish D, Rezaei N, Aljabali AAA, Ghosh S, Pizzol D, Chauhan G, Adadi P, Mohamed Abd El-Aziz T, Soares AG, Kandimalla R, Tambuwala M, Hassan SS, Azad GK, Pal Choudhury P, Baetas-da-Cruz W, Serrano-Aroca Á, Brufsky AM, Uhal BD. The structural basis of accelerated host cell entry by SARS-CoV-2†. FEBS J. 2021 09; 288(17):5010-5020. PMID: 33264497.
      Citations: 49     Fields:    Translation:HumansCellsPHPublic Health
    63. Hassan SS, Ghosh S, Attrish D, Choudhury PP, Aljabali AAA, Uhal BD, Lundstrom K, Rezaei N, Uversky VN, Seyran M, Pizzol D, Adadi P, Soares A, El-Aziz TMA, Kandimalla R, Tambuwala MM, Azad GK, Sherchan SP, Baetas-da-Cruz W, Takayama K, Serrano-Aroca Á, Chauhan G, Palu G, Brufsky AM. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features. Molecules. 2020 Dec 13; 25(24). PMID: 33322198.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    64. Mohamed Khosroshahi L, Rezaei N. Dysregulation of the immune response in coronavirus disease 2019. Cell Biol Int. 2021 Apr; 45(4):702-707. PMID: 33289192.
      Citations: 9     Fields:    Translation:HumansCells
    65. Ahanchian H, Moazzen N, Sezavar M, Khalighi N, Khoshkhui M, Aelami MH, Motevalli Haghi NS, Rezaei N. COVID-19 in a child with primary antibody deficiency. Clin Case Rep. 2021 Feb; 9(2):755-758. PMID: 33598240.
      Citations: 4     
    66. Citations: 18     Fields:    Translation:HumansPHPublic Health
    67. Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Rep. 2020 Nov 25. PMID: 33362925.
      Citations: 4     
    68. Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review. Bioorg Chem. 2021 01; 106:104490. PMID: 33261845.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    69. Jabbari P, Taraghikhah N, Jabbari F, Ebrahimi S, Rezaei N. Adherence of the General Public to Self-Protection Guidelines During the COVID-19 Pandemic. Disaster Med Public Health Prep. 2020 Nov 18; 1-4. PMID: 33203487.
      Citations: 2     Fields:    
    70. Torabi S, Bahreini F, Rezaei N. The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury. Acta Biomed. 2020 11 10; 91(4):e2020142. PMID: 33525252.
      Citations: 1     Fields:    Translation:Humans
    71. Shakerian N, Mofateh R, Saghazadeh A, Rezaei N, Rezaei N. Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19. Acta Biomed. 2020 11 10; 92(1):e2021020. PMID: 33682807.
      Citations: 1     Fields:    Translation:Humans
    72. Vakhshoori M, Heidarpour M, Shafie D, Taheri M, Rezaei N, Sarrafzadegan N. Acute Cardiac Injury in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2020 11 01; 23(11):801-812. PMID: 33220700.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    73. Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine. 2021 May; 85:153396. PMID: 33380375.
      Citations: 7     Fields:    Translation:HumansAnimals
    74. Hanaei S, Takian A, Majdzadeh R, Maboloc CR, Grossmann I, Gomes O, Milosevic M, Gupta M, Shamshirsaz AA, Harbi A, Burhan AM, Uddin LQ, Kulasinghe A, Lam CM, Ramakrishna S, Alavi A, Nouwen JL, Dorigo T, Schreiber M, Abraham A, Shelkovaya N, Krysztofiak W, Ebrahimi Warkiani M, Sellke F, Ogino S, Barba FJ, Brand S, Vasconcelos C, Salunke DB, Rezaei N. Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After the COVID-19 Pandemic. Disaster Med Public Health Prep. 2020 Oct 26; 1-6. PMID: 33100253.
      Citations: 5     Fields:    
    75. Yazdanpanah N, Saghazadeh A, Rezaei N. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. 2020 10 25; 31(7):691-701. PMID: 32776905.
      Citations: 16     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    76. Lundstrom K, Seyran M, Pizzol D, Adadi P, Mohamed Abd El-Aziz T, Hassan SS, Soares A, Kandimalla R, Tambuwala MM, Aljabali AAA, Kumar Azad G, Pal Choudhury P, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Viewpoint: Origin of SARS-CoV-2. Viruses. 2020 10 22; 12(11). PMID: 33105685.
      Citations: 7     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    77. Aleebrahim-Dehkordi E, Soveyzi F, Deravi N, Rabbani Z, Saghazadeh A, Rezaei N. Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children. J Pediatr Nurs. 2021 Jan-Feb; 56:70-79. PMID: 33186866.
      Citations: 4     Fields:    Translation:Humans
    78. Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med. 2021 Aug; 46:382-391. PMID: 33268238.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    79. Citations: 4     Fields:    Translation:HumansPHPublic Health
    80. Shojaeefar E, Malih N, Rezaei N. The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis. Cell Biol Int. 2021 Jan; 45(1):54-57. PMID: 32990980.
      Citations: 5     Fields:    Translation:HumansAnimals
    81. Sarzaeim M, Rezaei N. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19. SN Compr Clin Med. 2020 Oct 06; 1-6. PMID: 33043252.
      Citations: 5     
    82. Lotfi M, Rezaei N. CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother. 2020 Nov; 131:110738. PMID: 33152914.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    83. Mohamed K, Rezaei N. COVID-19 pandemic is not the time of trial and error. Am J Emerg Med. 2021 08; 46:774-775. PMID: 32988694.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    84. Goudarzi S, Dehghani Firouzabadi F, Dehghani Firouzabadi M, Rezaei N. Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2. Dermatol Ther. 2020 Nov; 33(6):e14266. PMID: 32882081.
      Citations: 3     Fields:    Translation:Humans
    85. Seyedpour S, Khodaei B, Loghman AH, Seyedpour N, Kisomi MF, Balibegloo M, Nezamabadi SS, Gholami B, Saghazadeh A, Rezaei N. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. J Cell Physiol. 2021 04; 236(4):2364-2392. PMID: 32901936.
      Citations: 22     Fields:    Translation:HumansAnimals
    86. Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020 09 07; 91(3):e2020018. PMID: 32921715.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    87. Mohamed K, Rezaei N, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, A Makka S, Joya M, Makuku R, Goda R, Zoghi S, Irtsyan S, Ling I, Attig-Bahar F, Hazar Sayar E, Soloukey C. International Efforts to Save Healthcare Personnel during COVID-19. Acta Biomed. 2020 09 07; 91(3):e2020044. PMID: 32921737.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    88. Sadeghmousavi S, Rezaei N. COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment. SN Compr Clin Med. 2020; 2(10):1802-1807. PMID: 32895640.
      Citations: 12     
    89. Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw. 2020 Sep 01; 31(3):81-93. PMID: 33361013.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    90. Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N. Microfluidic devices for detection of RNA viruses. Rev Med Virol. 2021 01; 31(1):1-11. PMID: 32844526.
      Citations: 10     Fields:    Translation:Humans
    91. Rokni M, Hamblin MR, Rezaei N. Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother. 2020 10 02; 16(10):2363-2365. PMID: 32841579.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    92. Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep. 2020 Aug 24; 14(1):134. PMID: 32838801.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    93. Pashaei M, Rezaei N. Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther. 2020 10; 20(10):1111-1116. PMID: 32762581.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    94. Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020 Oct 01; 258:118185. PMID: 32750438.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    95. Pourahmad R, Moazzami B, Rezaei N. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19. SN Compr Clin Med. 2020; 2(9):1407-1411. PMID: 32838178.
      Citations: 13     
    96. Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol. 2020 Oct 05; 884:173455. PMID: 32745604.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    97. Babaha F, Rezaei N. Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? Am J Med Sci. 2020 12; 360(6):740-741. PMID: 32773108.
      Citations: 21     Fields:    Translation:Humans
    98. Jabbari P, Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? Disaster Med Public Health Prep. 2020 08; 14(4):e33. PMID: 32713383.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    99. Jenab Y, Rezaei N, Hedayat B, Naderian M, Shirani S, Hosseini K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID-19. Clin Case Rep. 2020 Jul 22. PMID: 32837723.
      Citations: 3     
    100. Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. 2020 11; 92(11):2277-2282. PMID: 32619062.
      Citations: 15     Fields:    Translation:Humans
    101. Bahrami A, Vafapour M, Moazzami B, Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran. J Paediatr Child Health. 2021 06; 57(6):922-925. PMID: 32640066.
      Citations: 14     Fields:    Translation:Humans
    102. Rezaei N. COVID-19 and Medical Biotechnology. Avicenna J Med Biotechnol. 2020 Jul-Sep; 12(3):139. PMID: 32695275.
      Citations: 21     
    103. Jabbari P, Jabbari F, Ebrahimi S, Rezaei N. COVID-19: A Chimera of Two Pandemics. Disaster Med Public Health Prep. 2020 Jun; 14(3):e38-e39. PMID: 32580806.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    104. Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux AF, Janne P, Gourdin M, Delanghe JR, Ochs HD, Talmadge JE, Garg M, Hamblin MR, Rezaei N. Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol. 2020 Sep; 86:106711. PMID: 32585609.
      Citations: 11     Fields:    Translation:Humans
    105. Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020 10; 92(10):1864-1874. PMID: 32492197.
      Citations: 27     Fields:    Translation:Humans
    106. Jahanshahlu L, Rezaei N. Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother. 2020 Sep; 129:110337. PMID: 32534226.
      Citations: 50     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    107. Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020 Sep; 44(9):1792-1797. PMID: 32458561.
      Citations: 75     Fields:    Translation:HumansCellsPHPublic Health
    108. Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: Friend or foe? Life Sci. 2020 Sep 01; 256:117900. PMID: 32502542.
      Citations: 81     Fields:    Translation:HumansCellsPHPublic Health
    109. Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N. COVID-19 and picotechnology: Potential opportunities. Med Hypotheses. 2020 Nov; 144:109917. PMID: 32505072.
      Citations: 21     Fields:    Translation:HumansPHPublic Health
    110. Yousefzadegan S, Rezaei N. Case Report: Death due to COVID-19 in Three Brothers. Am J Trop Med Hyg. 2020 06; 102(6):1203-1204. PMID: 32277694.
      Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
    111. Citations: 38     Fields:    Translation:HumansCellsPHPublic Health
    112. Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020 Jun 01; 31(2):44-49. PMID: 32933891.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    113. Nasab MG, Saghazadeh A, Rezaei N. SARS-CoV-2-A Tough Opponent for the Immune System. Arch Med Res. 2020 08; 51(6):589-592. PMID: 32532524.
      Citations: 20     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    114. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020 Sep; 508:254-266. PMID: 32474009.
      Citations: 121     Fields:    Translation:HumansCellsPHPublic Health
    115. Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 2020 05 26; 31(4):453-456. PMID: 32463395.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    116. Jahanshahlu L, Rezaei N. Central Nervous System Involvement in COVID-19. Arch Med Res. 2020 10; 51(7):721-722. PMID: 32471704.
      Citations: 14     Fields:    Translation:Humans
    117. Citations: 55     Fields:    Translation:HumansCellsPHPublic Health
    118. Hanaei S, Rezaei N. COVID-19: Developing from an Outbreak to A Pandemic. Arch Med Res. 2020 08; 51(6):582-584. PMID: 32405122.
      Citations: 34     Fields:    
    119. Saghazadeh A, Rezaei N. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol. 2020 Jul; 84:106560. PMID: 32413736.
      Citations: 75     Fields:    Translation:HumansCellsPHPublic Health
    120. Darbeheshti F, Rezaei N. Genetic predisposition models to COVID-19 infection. Med Hypotheses. 2020 09; 142:109818. PMID: 32416414.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    121. Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N. Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infect Control Hosp Epidemiol. 2020 Oct; 41(10):1245-1246. PMID: 32319878.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    122. Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020 Sep; 41(9):1106-1107. PMID: 32297847.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    123. Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020 05; 16(5):465-470. PMID: 32237901.
      Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
    124. Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being. J Clin Virol. 2020 05; 126:104345. PMID: 32278298.
      Citations: 96     Fields:    Translation:HumansCellsPHPublic Health
    Rezaei's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (735)
    Explore
    _
    Co-Authors (608)
    Explore
    _
    Similar People (60)
    Explore
    _